NCT01489241

Brief Summary

The purpose of this study is to evaluate whether the introduction of a short-term telemonitoring program for chronic obstructive pulmonary disease (COPD) patients discharged from the hospital after disease exacerbation produces benefits in terms of a reduction in hospital readmissions and health related quality of life. In addition the trials evaluate the economical and organisational impact of the services and examine their acceptability by patients and health professionals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
155

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 6, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 9, 2011

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
Last Updated

February 24, 2015

Status Verified

February 1, 2015

Enrollment Period

2.7 years

First QC Date

December 6, 2011

Last Update Submit

February 21, 2015

Conditions

Keywords

Pulmonary Disease, Chronic ObstructiveTelemedicine

Outcome Measures

Primary Outcomes (1)

  • Number of hospital readmissions

    Number of hospital readmissions after the hospital discharged of the patient after a COPD exacerbation

    3 months period

Secondary Outcomes (6)

  • Health related quality of life of the patients as measured by the SF-36 version 2 questionnaire

    3 months - at the entry point of the intervention and the end.

  • Hospital anxiety and depression scale HADS

    3 months - at the entry point of the intervention and the end.

  • Health status, measured with the St. George's Respiratory Questionnaire SGRQ

    3 months - at the entry point of the intervention and the end.

  • Lung condition as measured by FEV1

    1 month after the hospital discharge.

  • Mortality

    3 months period

  • +1 more secondary outcomes

Study Arms (2)

Usual care

NO INTERVENTION

Patients in the control group receive usual care and visit the outpatient department at 4 and at 12 weeks after discharge when pulse rate, oxygen saturation and spirometry is performed. In the case of clinical deterioration during the study, the patients contact as usual their general practitioner. Usual care of COPD patients consists of regular visits to the specialist or primary care clinics every time a medication change is made or a medical examination is needed

Telemonitoring

EXPERIMENTAL
Procedure: Telemonitoring

Interventions

Within 24 hours after patient's discharge, the telemedicine equipment is installed at the patient's home and patients are trained in the use of the equipment. Patients are followed by a dedicated telehealth centre. Patients at home are asked to fill out each morning the CAT questionnaire and to record extra use of COPD relief medications. Patients in stable conditions perform telespirometry and teleoximetry at 4 and 12 weeks. When a clinical worsening is detected (increase in CAT score by 5 points or higher on two consecutive days) the patient is contacted and asked to perform ad hoc telespirometry and teleoximetry and to send the data to the telehealth centre.

Telemonitoring

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Exacerbation of COPD according to the GOLD guidelines
  • Age \> 40 years
  • Capability to use the devices provided
  • Willing to participate

You may not qualify if:

  • included in previous COPD monitoring study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pulmonary Department - Regional University Hospital of Larisa

Larissa, Thessaly, 41110, Greece

Location

Related Publications (1)

  • Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K, Scott RE. Home telehealth for chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Telemed Telecare. 2010;16(3):120-7. doi: 10.1258/jtt.2009.090812. Epub 2010 Mar 2.

    PMID: 20197355BACKGROUND

Related Links

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Konstantinos Gourgoulianis, MD, PhD

    Pulmonary Department - University Hospital of Larisa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Director of the Pulmonary Department, University Hospital of Larisa

Study Record Dates

First Submitted

December 6, 2011

First Posted

December 9, 2011

Study Start

March 1, 2011

Primary Completion

November 1, 2013

Study Completion

January 1, 2014

Last Updated

February 24, 2015

Record last verified: 2015-02

Locations